Related Experiment Video
Updated: May 18, 2026

06:40
Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy Model in Mice
Published on: February 10, 2023
Repeat sleeve gastrectomy compared with primary sleeve gastrectomy: a single-center, matched case study.
Lionel Rebibo1, David Fuks, Pierre Verhaeghe
1Department of Digestive Surgery, Amiens University Hospital and Jules Verne University of Picardie, Place Victor Pauchet, 80054, Amiens Cedex 01, France.
Obesity Surgery
|September 25, 2012
Summary
Repeat sleeve gastrectomy (re-SG) is a feasible option for morbid obesity treatment failures. While re-SG shows slightly lower excess weight loss and higher complication risks compared to first-line SG, it offers comparable weight management outcomes.
Area of Science:
- Bariatric Surgery
- Gastroenterology
- Obesity Medicine
Background:
- Longitudinal sleeve gastrectomy (LSG) is an established bariatric procedure for morbid obesity.
- Treatment failures can occur months after LSG, often necessitating further surgical intervention.
- Malabsorptive procedures are typically recommended following LSG failure.
Purpose of the Study:
- To evaluate the efficacy and safety of repeat sleeve gastrectomy (re-SG) compared to first-line SG.
- To assess outcomes including operative time, complications, and weight loss following re-SG.
Main Methods:
- Retrospective matched-cohort study comparing 15 patients who underwent re-SG with 30 patients who had undergone first-line SG.
- Patients were matched for age, gender, BMI, and comorbidities.
- Efficacy was assessed using intra-operative and postoperative data, including Excess Weight Loss (EWL) at 12 months.
Main Results:
- The re-SG group had a significantly longer mean operating time (116 vs. 86 minutes).
- The postoperative complication rate was higher in the re-SG group, with two cases of gastric fistula and one mortality.
- At 12 months, EWL was 66% in the re-SG group versus 77% in the first-line SG group (p=0.05).
Conclusions:
- Repeat sleeve gastrectomy (re-SG) is technically feasible for managing morbid obesity treatment failures.
- Re-SG is associated with an increased risk of complications and a trend towards lower EWL compared to primary LSG.
- Despite potential risks, re-SG can achieve weight loss results comparable to those of initial LSG.
